2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.

Bioorg Med Chem Lett

University of Pittsburgh Chemical Diversity Center, University of Pittsburgh, Pittsburgh, PA 15260, USA; Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA. Electronic address:

Published: November 2014

Synthesis and SAR investigation of 2-guanidinoquinazolines, initially identified in a high content screen for selective STAT3 pathway inhibitors, led to a more potent analog (11c) that demonstrated improved anti-proliferative activity against a panel of HNSCC cell lines.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250329PMC
http://dx.doi.org/10.1016/j.bmcl.2014.09.001DOI Listing

Publication Analysis

Top Keywords

stat3 pathway
8
2-guanidinoquinazolines inhibitors
4
inhibitors stat3
4
pathway synthesis
4
synthesis sar
4
sar investigation
4
investigation 2-guanidinoquinazolines
4
2-guanidinoquinazolines initially
4
initially identified
4
identified high
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!